Brad Robling

Board Member at Sitryx Therapeutics

Brad Robling is the Vice President Corporate Business Development / Lilly New Ventures at Eli Lilly and Company. As such, he is focused on managing Eli Lilly’s venture capital investments globally.

Org chart

View in org chart

Rich Aldrich

Board Member

Houman Ashrafian

Board Member

Kate Bingham

Board Member

Paul-Peter Tak

Board Member

Rab Prinjha

Board Member

Nikola Trbovic

Board Member

Maina Bhaman

Director

Pierre Legault

Chairman

View in org chart

Teams

Board of Directors

7 members

Timeline

Board Member
Current role